Analysed OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) News Sources
Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA
07-04-2026
yahoo.com
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note
16-03-2026
yahoo.com
Outlook Therapeutics Provides Update Following Type A Meeting with FDA Regarding ONS-5010/LYTENAVA™ (bevacizumab-vikg)
05-03-2026
yahoo.com
Outlook Therapeutics Expands European Footprint with Exclusive Commercial Distribution Agreement with Mediconsult AG for LYTENAVA™ (bevacizumab gamma) in Switzerland
19-02-2026
yahoo.com
Outlook Therapeutics Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
17-02-2026
yahoo.com
What is the current price of OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ)?
The current price of OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) is $0.3102.
OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) absolute price change since previous trading day?
The absolute price change of OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) since the previous trading day is $0.0398.
OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) percentage price change since previous trading day?
The percentage price change of OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) since the previous trading day is 14.7189%.
What is the most recent average sentiment score for OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ)?
The most recent average sentiment score for OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ)?
The most recent sentiment for OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) is .
SEC-8K** Filing Available For OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.